LFMD - Earnings announcements

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets on May 6, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, May 6thTime:4:30 p.m. Eastern timeToll-Free Dial-In:877-270-2148International Dial-In:412-902-6510Conference ID:LifeMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 9thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-343-5172International Dial-In:203-518-9856Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy ser

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third quarter 2025 earnings release and conference call to Monday, November 17, 2025. The Company expects to file a Form 12b-25, as needed, notifying the U.S. Securities and Exchange Commission of a late filing of its Form 10-Q for the period ended September 30, 2025. The change to LifeMD's third quarter 2025 earnings release date relates to corrections the Company identified related to the recognition of revenue with offsetting related balance sheet accounts for the twelve months ended December 31, 202

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on November 6, 2025, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Thursday, November 6thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-245-3047International Dial-In:203-518-9765Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and ph

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025. Second Quarter 2025 Revenue: $105.6 million, with revenue per active earning coach of $4,630 Active Coaches: Independent active earning OPTAVIA coaches of 22,800 Net Income: $2.5 million or $0.22 per diluted share, which includes a gain on investment in LifeMD (NASDAQ:LFMD) common stock of $2.0 million (net of tax) Strong Balance Sheet: $162.7 million in cash, cash equivalents, and investment securities with no debt "We are working diligently to transform our business as we look to he

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on August 5, 2025, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Tuesday, August 5thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-445-7795International Dial-In:785-424-1699Conference ID:LIFEMDLive & Archived Webcast:Link About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pha

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended June 30, 2025 on Monday, August 4, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 4, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https:

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (NASDAQ:LFMD) common stock of $0.4 million (net of tax) Loss per share of $0.07 Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt "In today's health and wellness landscape, more people than ever are seeking guidance not just for we

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Tuesday, May 6thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-225-9448International Dial-In:203-518-9708Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, a

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended March 31, 2025 on Monday, April 28, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on April 28, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https:

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on March 10, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 10thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-225-9448International Dial-In:203-518-9708Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc.LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy servi

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Revenue of $119.0 million, with revenue per active earning coach of $4,391 Independent active earning OPTAVIA coaches of 27,100 Net income of $0.8 million (non-GAAP adjusted net income of $1.1 million) Earnings per diluted share ("EPS") of $0.07 (non-GAAP adjusted EPS of $0.10) Cash, Cash Equivalents, and Investment Securities of $162.3 million and no debt Full Year 2024 Revenue of $602.5 million Net income of $2.1 million (non-GAAP adjusted net i

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on February 18, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.Medif

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ended September 30, 2024. Third Quarter 2024 Revenue of $140.2 million, with revenue per active earning coach of $4,672 Independent active earning OPTAVIA coaches of 30,000 Net income of $1.1 million (non-GAAP adjusted net income of $3.9 million) Income per diluted share of $0.10 (non-GAAP adjusted earnings per share ("EPS") of $0.35) Cash, Cash Equivalents, and Investment Securities of $170.0 million with no debt "Medical innovation has transformed the weight loss industry, so at Medifast we're creating a hea

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial markets on November 7, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Thursday, November 7thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-717-1738International Dial-In:646-307-1865Conference ID:73461Live & Archived Webcast:Link   About LifeMD, Inc.LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmac

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on November 4, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or dire

Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67%Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000Weight management subscribers exceeded 60,000 as of June 30, 2024Adjusted EBITDA increased 44% to $2.5 millionCash of $35.7 million as of June 30, 2024, and positive net cash flow in three of the last four quarters Conference call begins at 4:30 p.m. Eastern time today NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today reported financial results for the three and six months ended June 30, 2024. Management Commentary "L

Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenue of $168.6 million, with revenue per active earning Coach of $4,972 Independent active earning OPTAVIA Coaches of 33,900 Net loss of $8.2 million (non-GAAP adjusted net income of $10.1 million) Loss per diluted share of $0.75 (non-GAAP adjusted earnings per share ("EPS") of $0.92) Cash, Cash Equivalents, and Investment Securities of $163.5 million with zero debt "We are acting decisively to transform our business to position us for long-term growth, with

NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on August 7, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, August 7thTime:4:30 p.m. Eastern timeToll-Free Dial-In:1-800-245-3047International Dial-In:1-203-518-9765Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc.LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, an

Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2024 on Monday, August 5, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 5, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at

First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period.Raising full-year revenue guidance to at least $205 million, up from prior guidance of at least $200 million.Growth in all business segments, with weight management subscribers growing to 42,000 as of March 31, 2024. As of today, weight management subscribers exceed 50,000.Including the increase in deferred revenue from prepaid weight management subscriptions, cash-adjusted EBITDA was $4.8 million, a 108% increase versus the comparable measure in the year-ago period. Excluding this increase, adjusted EBITDA for the first quarter was $0.5 million.Generated $5.2 mi

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on May 8, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, May 8thTime:4:30 p.m. Eastern timeToll-Free Dial-In:1-888-886-7786International Dial-In:1-416-764-8658Conference ID:51137398Live & Archived Webcast:Link   About LifeMD, Inc.LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and spec

Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of $0.15 per share compared with $0.02 in the year-ago period.Consolidated adjusted EBITDA of $5.5 million compared with $1.0 million in the year-ago period.Weight Management subscribers exceeded 22,000 as of year-end 2023, ahead of previous guidance.Telehealth subscribers grew 27% year-over-year to a record 215,000 patients at year-end 2023. Conference call begins at 4:30 p.m. Eastern time today NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today reported financial resul

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2023 after the close of the U.S. financial markets on March 11, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 11thTime:4:30 p.m. Eastern timeToll-Free Dial-In:1-877-704-4453International Dial-In:1-201-389-0920Conference ID:13743864Live & Archived Webcast:Link  About LifeMD, Inc.LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy

Health and wellness company makes $20 million capital commitment to LifeMD, enters medically supported weight loss market projected to reach up to $100 billion by 2030 Company discontinues quarterly cash dividend and intends to invest in initiatives aimed at driving customer acquisition and customer experience to reignite growth Conference call to discuss Medifast and LifeMD collaboration begins at 10 AM EST today Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today launched the first phase of its business transformation, as part of its commitment to providing comprehensive health and wellness solutions to c

Collaboration will integrate LifeMD's telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle solution Medifast has invested $20 million, including a $10 million payment in support of the collaboration and a $10 million purchase of LifeMD common stock Conference call to discuss LifeMD and Medifast collaboration begins at 10:00 AM EST today NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) --  LifeMD, Inc.TM (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced a strategic alliance with Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA

Revenue increased 23% year-over-year to $38.6 million with both telehealth and WorkSimpli achieving record revenues.Adjusted EPS of $0.08 per share compared with a loss of $0.03 in the year-ago period.Consolidated adjusted EBITDA increased to $2.8 million compared with a loss of $0.8 million in the year-ago period, and a 60% improvement versus the second quarter of 2023.Weight Management revenue more than quadrupled versus the second quarter of 2023.Telehealth subscribers grew 22% year-over-year to a record 207,000 patients. Conference call begins at 4:30 p.m. Eastern time today NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual prim

NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2023 after the close of the U.S. financial markets on November 8, 2023 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, November 8thTime:4:30 p.m. Eastern timeToll-Free Dial-In:1-877-704-4453International Dial-In:1-201-389-0920Conference ID:13741419Live & Archived Webcast:Link   About LifeMD, Inc.LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy

Revenue grew 18% year-over-year to a record $35.9 million; telehealth net revenues increased 11% versus the first quarter of 2023.Achieved positive free cash flow, ahead of guidance.Adjusted EBITDA increased to $1.7 million in the second quarter 2023 from an adjusted EBITDA loss of $6.9 million in the year-ago period.Launched a comprehensive Weight Management program offering and onboarded over 5,000 new patient subscribers to date; the Weight Management program is expected to be substantially accretive beginning in 2024.Raised 2023 revenue guidance to $146 million to $152 million, reflecting early success with the Weight Management program. Conference call begins at 4:30 p.m. Eastern

NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended June 30, 2023 after the close of the U.S. financial markets on August 9, 2023 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, August 9thTime:4:30 p.m. Eastern TimeToll-Free Dial-In:1-877-704-4453International Dial-In:1-201-389-0920Conference ID:13739131Live & Archived Webcast:Link About LifeMD™LifeMD is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics,

Record first quarter 2023 consolidated revenue of $33.1 million, up 14% from the same year-ago period.Record Adjusted EPS of $0.06 per share, up 126% versus the prior year.Record Adjusted EBITDA of $2.0 million, up 126% versus the prior year.Executed debt financing transaction with Avenue Capital, providing up to $40 million of total capital and strengthening LifeMD's long-term capital position.Re-affirm Full Year 2023 revenue guidance of $140 to $150 million and consolidated Adjusted EBITDA guidance of $12 to $18 million. NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) --  LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, reported results for the first quarter ended M

NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market open on Friday, May 12, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30am Eastern Time. Conference Call & Webcast Details: Date:Friday, May 12thTime:8:30am ETToll Free:1-877-704-4453International:1-201-389-0920 Conference ID:13738585Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1613338&tp_key=c0937faa82 About LifeMDLifeMD is a 50-state direct-to-patient tele

NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Wednesday, March 22, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Conference Call & Webcast Details: Date:Wednesday, March 22ndTime:4:30pm ETToll Free:1-877-704-4453International:1-201-389-0920 Conference ID:13736906Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1602716&tp_key=5d40c4c9f6 About LifeMDLifeMD is a 5

Fourteenth consecutive quarter of record consolidated revenue. Third quarter 2022 consolidated revenue of $31.4 million up 26% from the same year ago period.Adjusted EPS of $(0.03), 91% improvement versus the prior year, 86% sequentially versus prior quarter.Remain on track to achieve consolidated Adjusted EBITDA profitability in fourth quarter 2022.Consolidated Adjusted EBITDA loss for the third quarter reduced to $889,000. NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, reported results for the third quarter ended September 30, 2022. All figure comparisons are to the same year-ago quarter unless otherwise noted. Man

NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the third quarter ended September 30, 2022 after the market close on Thursday, November 10, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Conference Call & Webcast Details: Date:Thursday, November 10thTime:4:30pm ETToll Free:1-800-218-2154International:1-720-543-0214 Conference ID:1668855Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1580105&tp_key=82ee8cfb68 About LifeMDLifeMD is a 50-state dire

Record second quarter 2022 consolidated revenue of $30.5 million up 37% from the same year ago period.Adjusted EPS of $(0.22), 52% improvement versus the prior year, 12% sequentially.Remain on track to deliver consolidated Adjusted EBITDA profitability by fourth quarter 2022.Consolidated Adjusted EBITDA loss was reduced to below $1 million in the month of June.LifeMD published a second quarter Supplemental Investor Highlights Presentation, available on the Company's Investor Relations site, ir.lifemd.com or via direct download at https://ir.lifemd.com/q2. NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, reported result

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the second quarter ended June 30, 2022 after the market close on Thursday, August 11, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Conference Call & Webcast Details: Date:Thursday, August 11thTime:4:30pm ETToll Free:1-800-263-0877International:1-720-543-0197 Conference ID:9480029Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1560537&tp_key=0592b1380e About LifeMDLifeMD is a 50-state direct-to-pa

First quarter 2022 consolidated revenue of $29.0 million up 60% from the same year ago period.Adjusted EPS of $(0.25), 14% sequential improvement versus the prior quarter.Re-affirm Full Year Adjusted EBITDA guidance and remain on track to reach Consolidated Adjusted EBITDA profitability by fourth quarter 2022.Cash balance of $25.1 million as of March 31, 2022 with no debt. Cash Flow during the quarter included $7 million of one-time cash outflows related to two acquisitions and related working capital investments. NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, reported results for the first quarter ended March 3

NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced that it will report its financial results for first quarter ended March 31, 2022 before the market open on Friday, May 13, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:00 am Eastern Time. Conference Call & Webcast Details:Date: Friday, May 13Time: 8:00 am ETToll Free: 1-877-704-4453International: 1-201-389-0920Conference ID: 13729668Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1546399&tp_key=1ae89baf0a About LifeMDLifeMD™ is a 50-state direct-to-patient telehealt

NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the year ended December 31, 2021 after the market close on Monday, March 7, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Conference Call & Webcast Details: Date:Monday, March 7Time:4:30pm ETToll Free:1-877-705-6003 International:1-201-493-6725 Conference ID:13727334 Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1531128&tp_key=11506307b8 About LifeMDLifeMD is a 50-state direct-to-patient telehea

NEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. ("the Company") (NASDAQ:LFMD) is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications and over the counter products to patients across all 50 states. The Company today announced that it will host a conference call to discuss its financial results for third quarter fiscal 2021, on Wednesday, November 10, 2021 after the close of market. The financial results will be issued in a press release prior to the call. LifeMD management will host the conference call followed by a question-and-answer period. Conference Call: Date: Wednesday, November 10, 2021Time: 5:00

New patient Customer Acquisition Cost (CAC) decreased 8% sequentially, while new patient acquisitions per day for comparable brands increased 11%Revenue increased to a record $22.3 million, up 145% from the same year-ago period93% of Q2 2021 revenue generated by subscriptions, up from 56% in the same year-ago periodPlatform Contribution of $16.5 million, 74% of net revenue, up 145% from the same year-ago periodTotal telehealth order volume grew 155% to 199,764 NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, reported results for the second quarter ended June 30, 2021. All figure comparisons are to the same year-ago qua

NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. ("the Company") (NASDAQ:LFMD) is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications and over the counter products to patients across all 50 states. The Company today announced that it will host a conference call to discuss its financial results for second quarter fiscal 2021, on Thursday, August 12, 2021 after the close of market. The financial results will be issued in a press release prior to the call. LifeMD management will host the conference call followed by a question-and-answer period. Conference Call: Date: Thursday, August 12, 2021Time: 4:30 p